PharmaSGP Holding SE

WKN: A2P4LJ
ISIN: DE000A2P4LJ5
Land: Deutschland

Nachricht vom 25.06.2020 | 11:09

PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

PharmaSGP Holding SE
25.06.2020 / 11:09
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Name:	PharmaSGP Holding SE
Street:	Lochhamer Schlag 21
Postal code:	82166
City:	Gräfelfing Germany
Legal Entity Identifier (LEI):	3912005CZ12PVVCIPT91

2. Reason for notification

X	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
	Change of breakdown of voting rights
X	Other reason: acting in concert

3. Details of person subject to the notification obligation

Natural person (first name, surname): Dr. Clemens Fischer
Date of birth: 28 May 1975

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

FUTRUE GmbH, MVH Beteiligungs- und Beratungs-GmbH

5. Date on which threshold was crossed or reached:

23 Jun 2020

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	Total of both in % (7.a. + 7.b.)	Total number of voting rights pursuant to Sec. 41 WpHG
New	66.46 %	0.00 %	66.46 %	12,000,000
Previous notification	100.00 %	0.00 %	100.00 %	/

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)

ISIN	Absolute		In %
	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)
DE000A2P4LJ5	0	7,975,000	0.00 %	66.46 %
Total	7,975,000		66.46 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
			0	0.00 %
		Total	0	0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
				0	0.00 %
			Total	0	0.00 %

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least 3% or more)	% of voting rights through instruments (if at least 5% or more)	Total of both (if at least 5% or more)
Dr. Clemens Fischer	%	%	%
FUTRUE GmbH	66.46 %	%	66.46 %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:

Proportion of voting rights	Proportion of instruments	Total of both
%	%	%

10. Other explanatory remarks:

On the basis of a voting trust agreement between FUTRUE GmbH and MVH Beteiligungs- und Beratungs-GmbH, FUTRUE GmbH and MVH Beteiligungs- und Beratungs-GmbH mutually allocate the voting rights with regard to all shares they hold in PharmaSGP Holding SE.

Date

24 Jun 2020

25.06.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	PharmaSGP Holding SE
	Lochhamer Schlag 21
	82166 Gräfelfing
	Germany
Internet:	https://sgp-pharma.com


End of News	DGAP News Service

Kurschart

Kursdetails anzeigen

Interaktiv

DGAP-Watchlist

zur Registrierung

Übersicht Indizes

weitere Indizes

Weitere News

weitere News anzeigen

GBC-Fokusbox

International School Augsburg (ISA) – erste Schule in Deutschland geht an die Börse

Die International School Augsburg – ISA- gemeinnützige AG geht als erste Schule in Deutschland an die Börse und macht damit erstmals das Thema „Bildung“ unter ESG-Kriterien investierbar. Mit dem geplanten Emissionserlös soll ein Campus-Neubau finanziert werden, um die hohe Nachfrage bedienen zu können. In unserer Researchstudie haben wir die hohe Bedeutung der ISA für den regionalen Wirtschaftsstandort, eine hohe Stabilität der Geschäftsentwicklung sowie hohe Sicherheiten durch vorhandene Sachwerte ermittelt. Das Rating lautet KAUFEN.

Zur Studie